0.51 0.39 o.12 30.86 TM Revenue 39.38 39.55 29.71 9.84 33.13 Costs of Sales (27.78) (27.84) (20.82) 7.02 33.74 Selling Expenses {2.7e) (2.7e) Q.67) o.12 4.62 Administrative Expenses (3.83) (3.82) (3.34
cost) 2,135.19 1,588.22 546.97 34.4 Revenue from finance lease contract 738.69 853.62 (114.93) (13.5) Share of profit of associates / joint ventures 1,281.83 1,727.16 (445.33) (25.8) Other incomes 232.17
volume. Gross Profit Margin Gross profit margin is equal to 32.30% in 2Q17, which slightly declined from the same period of last year which was 33.83%. The main cause stemmed from the duplicated costs of
) (49.14) Per Share (Baht) Net profit per share 0.02 0.05 (0.02) Unit : THB'000 NO. AC. 003/2017 11 August 2017 Subject: Clarification of changes in operating performance of more than 20% To: The President
and administrative costs and expenses increased by 0.41%, compared to the same period of the previous year. The main reasons were as follows; Selling costs decreased by 0.02% because electric power
selling medical equipment 60.65 73.92 Administrative expenses 109.64 105.99 Finance costs 22.86 24.24 Finance costs (net) 20.87 21.71 Proportion of cost of medical treatment / revenue of medical treatment
sales costs equaled 160.8 million baht and the sales costs for 2016 equaled 154.7 million baht for percentages of 88.89 and 90.47, respectively. As a result, the Company made a gross profit of 20.1
Incomes 78.14 60.33 Total Revenues 7,879.44 7,032.50 Selling & Administrative Expense 507.94 499.86 Finance Costs 90.76 94.42 Net Profit 443.44 121.25 Earnings per share (Baht) 1.11 0.30 The company would
negative effect from strengthen THB against USD. * Note Please find further information in the consolidated financial statements. 2 Gross profit margin = Gross Profit (Total Sales – Costs of Sales) to Sales
590.59 553.11 Cost of selling medical equipment 65.30 57.70 Administrative expenses 112.97 109.49 Finance costs 19.32 24.93 Finance costs (net) 16.90 22.87 Proportion of cost of medical treatment / revenue